Efficacy and Safety of ES16001 in Patients With COVID-19
Clinical trial NCT05525182 · UNKNOWN
Trial details
- NCT number
- NCT05525182
- Sponsor
- Genencell Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-05
- Primary completion
- 2023-12-31
- Enrollment
- 706
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.